Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
501,650,900
-
Total 13F shares
-
467,231,375
-
Share change
-
-8,638,904
-
Total reported value
-
$4,698,802,420
-
Put/Call ratio
-
59%
-
Price per share
-
$10.06
-
Number of holders
-
339
-
Value change
-
-$72,072,911
-
Number of buys
-
180
-
Number of sells
-
195
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) as of Q2 2023
As of 30 Jun 2023,
Elanco Animal Health Inc - Common Stock (ELAN) was held by
339 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
467,231,375 shares.
The largest 10 holders included
Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., SHAPIRO CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Black Creek Investment Management Inc., CITADEL ADVISORS LLC, Balyasny Asset Management L.P., and STATE STREET CORP.
This page lists
343
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.